Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.

Item
http://www.wikidata.org/entity/Q40092107
New perspectives for targeting RAF kinase in human cancer.A Braf kinase-inactive mutant induces lung adenocarcinoma.Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.Colorectal cancer genomics and designing rational trials.Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation.Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.Hierarchical Organization Endows the Kinase Domain with Regulatory PlasticityThe Winding Roadmap of Biomarkers toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal CancerGround-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights
P2860

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.

Item
http://www.wikidata.org/entity/Q40092107
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.
@en
type
label
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.
@en
prefLabel
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P6179
P698
P932
P356
P1433
P1476
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P6179
P698
P932